Skip to content

Drug interactions

Erdafitinib + Mefenamic acid

Severity: Moderate

Erdafitinib and Mefenamic acid: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Erdafitinib is cleared mainly by CYP2C9 and CYP3A4, and mefenamic acid is a CYP2C9 substrate and inhibitor of modest potency. Higher erdafitinib exposure could increase adverse effects such as hyperphosphatemia, ocular toxicity, stomatitis and skin or nail disorders.

What this interaction means in plain words

Erdafitinib and Mefenamic acid can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Erdafitinib belongs to Oncology; Mefenamic acid belongs to Musculoskeletal.

Evidence level: Low

Why it happens

Inhibition of CYP2C9-mediated erdafitinib metabolism by mefenamic acid may raise erdafitinib plasma concentrations.

What to do

Prefer a different analgesic. If the combination is needed, monitor for erdafitinib toxicity such as serum phosphate, eye and skin effects and reduce the dose if adverse reactions occur.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Erdafitinib and Mefenamic acid, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Erdafitinib with Mefenamic acid?

MediHelp rates the interaction as moderate. Erdafitinib and Mefenamic acid can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Erdafitinib is cleared mainly by CYP2C9 and CYP3A4, and mefenamic acid is a CYP2C9 substrate and inhibitor of modest potency. Higher erdafitinib exposure could increase adverse effects such as hyperphosphatemia, ocular toxicity, stomatitis and skin or nail disorders.

How serious is the interaction between Erdafitinib and Mefenamic acid?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Prefer a different analgesic. If the combination is needed, monitor for erdafitinib toxicity such as serum phosphate, eye and skin effects and reduce the dose if adverse reactions occur.

What other medicines interact with Mefenamic acid?

MediHelp also lists interactions of Mefenamic acid with, for example, Ketorolac intranasal, Ketorolac, Aceclofenac. The full list is on the Mefenamic acid page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in